S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
LON:AVCT

Avacta Group (AVCT) Share Price, News & Analysis

GBX 49.75
+0.75 (+1.53%)
(As of 03/28/2024 04:30 PM ET)
Today's Range
47.33
50
50-Day Range
49
108.50
52-Week Range
47.33
166.98
Volume
3.37 million shs
Average Volume
2.39 million shs
Market Capitalization
£174.38 million
P/E Ratio
N/A
Dividend Yield
3.97%
Price Target
N/A
AVCT stock logo

About Avacta Group Stock (LON:AVCT)

Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms. The company develops AVA6000, FAPa-activated doxorubicin that is in Phase I clinical trial for treating locally advanced or metastatic-selected solid tumors; AVA3996, a tumor-targeted proteasome inhibitor based on bortezomib; AVA-028-PD-L1 Affimer/ImmunoCytokines; AVA-021 - PD-L1 Affimer/LAG-3 Affimer; and TMAC platform that utilizes the proprietary pre|CISION substrate to provide for the selective release of a drug moiety by FAPa. The company has a collaboration agreement with LG Chem for developing and commercializing LR19128 PD-L1 XT; and collaboration and license agreement with Avacta and Daewoong Pharmaceutical Co. Ltd. for developing AFX-001 for solid organ transplant and graft vs host Disease, and AFX-002 for multiple sclerosis. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.

AVCT Stock Price History

AVCT Stock News Headlines

The ProTrader Dashboard is simple to use! (trade demo inside)
Top traders like Kathy, Philip, Matt and Michael made out like bandits… “Took 65% profit on VFC today! Thanks!” - Kathy L. “Made 72% on VFC” - Philip “VFC was good, made $1,000 bucks” - Matt (estimated starting stake $1K) “VFC crushed it… Up 114% for a $3,249 profit!” - Michael It’s all thanks to the all-new ProTrader Dashboard… And today’s your chance to become one of the lucky ones to discover it for yourself.
Avacta Group: Appointment of Chief Business Officer
Appointment of Chief Business Officer
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Avacta Group Share Chat
AVCT.L - Avacta Group Plc
Block Listing Application to AIM
Avacta Group Plc (AVCT.L)
LG Chem Renews License Triggering Payment to Avacta
Avacta full-year results push shares higher
See More Headlines
Receive AVCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avacta Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/28/2020
Today
3/29/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

Net Income
£-42,080,000.00
Net Margins
-267.00%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£16.02 million
Cash Flow
GBX 3.32 per share
Book Value
GBX 8 per share

Miscellaneous

Free Float
N/A
Market Cap
£174.38 million
Optionable
Not Optionable
Beta
1.21
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. David Alastair Maclaughlin Smith (Age 58)
    CEO & Executive Director
    Comp: $444k
  • Mr. Tony Gardiner (Age 53)
    CFO, Company Secretary & Executive Director
    Comp: $273k
  • Dr. Christina Marie Coughlin B.S. (Age 54)
    M.D., Ph.D., Head of Research & Development, Interim Chief Medical Officer and Director
    Comp: $37k
  • Ms. Emma Wright
    Group In-House Counsel
  • Mr. Michael Vinegrad
    Group Communications Director
  • Mr. R. Craig Slater FCA (Age 60)
    Chief Operating Officer of Diagnostics
    Comp: $69k
  • Dr. Matt Johnson
    Chief Scientific Officer of Diagnostics
  • Dr. Fiona McLaughlin FSB (Age 54)
    Ph.D., Chief Scientific Officer of Therapeutics Division
  • Mr. David Wilson
    Chief Commercial Officer of Diagnostics
  • Ms. Karen Harrison
    Chief Operating Officer of Therapeutics Division

AVCT Stock Analysis - Frequently Asked Questions

How have AVCT shares performed in 2024?

Avacta Group's stock was trading at GBX 116.50 on January 1st, 2024. Since then, AVCT stock has decreased by 57.3% and is now trading at GBX 49.75.
View the best growth stocks for 2024 here
.

How were Avacta Group's earnings last quarter?

Avacta Group Plc (LON:AVCT) issued its earnings results on Monday, September, 28th. The biotechnology company reported ($3.74) EPS for the quarter. Avacta Group had a negative trailing twelve-month return on equity of 143.33% and a negative net margin of 267.00%.

What other stocks do shareholders of Avacta Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avacta Group investors own include Legal & General Group (LGEN), SkinBioTherapeutics (SBTX), Augean (AUG), 7digital Group (7DIG), American Airlines Group (AAL), ACI Worldwide (ACIW), Akero Therapeutics (AKRO), Advanced Micro Devices (AMD) and Amyris (AMRS).

How do I buy shares of Avacta Group?

Shares of AVCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:AVCT) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners